生検ガイダンスシステム市場：製品、用途、最終用途別-2024～2030年の世界予測

生検ガイダンスシステム市場規模は2023年に14億4,000万米ドルと推定され、2024年には15億4,000万米ドルに達し、CAGR 7.34%で2030年には23億8,000万米ドルに達すると予測されています。

生検ガイダンスシステム市場には、医師が生検を行う部位を正確に特定するための医療機器やソフトウェアの販売・開拓が含まれます。これらの生検ガイダンスシステムは、超音波、磁気共鳴画像法（MRI）、コンピュータ断層撮影法（CT）、その他の画像誘導技術などの様々なモダリティを利用し、生検のための異常組織の正確な位置と標的をリアルタイムで支援します。がんや消化器疾患の増加により、生検ガイダンスシステムのニーズが高まっています。乳がん治療・診断に対する意識の高まりと低侵襲生検治療への嗜好の高まりが市場成長に大きく寄与しています。しかし、生検ガイダンスシステムの製造にかかるコストが高いため、生検ガイダンスシステムの採用が制限される可能性があります。また、生検ガイダンスシステムに関連する技術的な複雑さも市場成長の懸念材料となっています。さらに、生検ガイダンスシステムの技術的進歩は、市場に大きな成長の可能性をもたらすと期待されています。また、ヘルスケアインフラとヘルスケア支出の改善も、市場成長にとって魅力的な機会を生み出すと予測されています。

製品画像処理能力の向上により超音波ガイド下生検への傾向が高まる

MRIガイド下生検は、磁気共鳴画像法（MRI）を利用して体内の病変の正確な位置を特定し、組織を採取する低侵襲の手技です。MRIガイド下生検は、超音波やX線画像で病変が確認できない場合に、異常部位にアクセスするのに適しています。定位ガイド下生検は、特に乳房組織内の疑わしい部位を見つけ、採取するためにマンモグラフィ画像を用います。定位ガイド下生検は精度が高く、費用対効果も高いため、外来での生検に適しています。超音波ガイド下生検は広く採用されている手技で、組織採取のための針留置を超音波検査で補助します。超音波ガイド下生検は特に触知可能な腫瘤に適しており、乳房、甲状腺、肝臓、腎臓、その他の軟部組織の生検によく用いられ、リアルタイムの画像診断が可能です。

応用例乳房生検の精度を高めるためのアプリケーションの改善

生検ガイダンスシステムは、周囲の健康な組織へのダメージを最小限に抑え、精度を向上させる脳生検に不可欠です。定位生検フレームや神経ナビゲーションシステムなどの先進的な生検ガイダンスシステムにより、外科医は脳内の病変の正確な位置を特定することができ、手技の侵襲を減らし、全体的な治療成績を向上させることができます。生検ガイダンスシステムは、乳房生検において、組織サンプリング手技の正確性のために重要です。3D画像やコンピュータ支援検出などの生検ガイダンス技術の革新は、乳房生検の精度を高め、従来の方法では追跡が困難な病変の同定に役立っています。

エンドユーザー病院における生検ガイダンスシステムの採用により、診断用途での高品質イメージングが可能になります。

診断センターは、患者の状態を診断するために医療検査や画像診断を行う施設です。このようなセンターでは、スペースの制約に対応するため、設置面積が小さく、費用対効果の高い生検ガイダンスシステムが好まれる傾向にあります。病院は一次医療施設であり、多くの患者数と幅広い処置ニーズに対応できる包括的な生検ガイダンスシステムを必要とします。これらのシステムは、より高い画像品質と複数の病院部門と連携する相互運用性を提供する必要があります。研究機関や学術機関では、実験的・教育的な処置に生検ガイダンスシステムを利用することが多いです。腫瘍科や消化器科などの専門クリニックでは、特定の種類の生検に特化した生検ガイダンスシステムが必要です。このようなクリニックでは、精度が高く、頻繁に遭遇する特定の解剖学的構造や病態に合わせた生検システムを必要としています。

地域別の洞察

南北アメリカ地域は、高度なヘルスケア・インフラの存在、より高いヘルスケア支出、早期診断と個別化医療の重視を特徴としており、これが高度な生検ガイダンスシステムの必要性を煽っています。さらに、この地域はがん診断の性能向上を目指す革新的な新興企業や既存企業の拠点であり続けています。欧州連合（EU）は、強力なヘルスケア政策と確立された償還の枠組みにより、生検ガイダンスシステムが広く採用されています。先進医療機器を中心とした質の高いヘルスケアが重視されています。EUの規制環境はまた、資金援助イニシアティブを通じて技術革新を支援し、官民の研究協力を促進しています。アジア太平洋は、生検ガイダンスシステム市場において急成長している地域です。中国では、ヘルスケアへの大規模な投資とがんに対する国民の意識の高まりが、生検ガイダンスシステムの必要性を後押しする主要因となっています。中国政府のヘルスケア改革への取り組みと新興医療技術の重視が、高度生検システムの採用を後押ししています。技術革新、高いヘルスケア水準、急速な高齢化が日本の生検ガイダンスシステムニーズを後押ししています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは生検ガイダンスシステム市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、生検ガイダンスシステム市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.生検ガイダンスシステム市場の市場規模および予測は？

2.生検ガイダンスシステム市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.生検ガイダンスシステム市場の技術動向と規制枠組みは？

4.生検ガイダンスシステム市場における主要ベンダーの市場シェアは？

5.生検ガイダンスシステム市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 診断処置を必要とするがんや慢性疾患の発生率の増加
    • 低侵襲生検治療への関心が高まる
    • 早期診断のための政府のキャンペーンと取り組み
  • 抑制要因
    • 専門的な訓練の必要性と生検システムの不正確さ
  • 機会
    • 生検誘導システムの技術的進歩
    • 生検処置に対する有利な償還ポリシー
  • 課題
    • 生検ガイダンスシステムに関連する技術的な複雑さ
• 市場セグメンテーション分析
  • 製品：イメージング機能の向上を目指した超音波ガイド下生検への関心の高まり
  • アプリケーション：乳房生検の精度向上のためのアプリケーションの改善
  • 最終用途：診断アプリケーション用の高品質画像を可能にするために病院で生検ガイダンスシステムを採用
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 生検ガイダンスシステム市場：製品別

• MRIガイド下生検
• 定位ガイド下生検
• 超音波ガイド下生検

第7章 生検ガイダンスシステム市場：用途別

• 脳生検
• 乳房生検
• 肺
• 前立腺

第8章 生検ガイダンスシステム市場：最終用途別

• 診断センター
• 病院
• 調査・学術機関
• 専門クリニック

第9章 南北アメリカの生検ガイダンスシステム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の生検ガイダンスシステム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの生検ガイダンスシステム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • FDA、乳房生検用のMRI対応ロボットシステムを承認
  • ストライカー、頭蓋ガイダンスソフトウェアを搭載したQガイダンスを発売
  • GEヘルスケア、介入ガイダンスの能力強化のためIMACTIS買収契約を発表
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. BIOPSY GUIDANCE SYSTEM MARKET RESEARCH PROCESS
• FIGURE 2. BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. BIOPSY GUIDANCE SYSTEM MARKET DYNAMICS
• FIGURE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. BIOPSY GUIDANCE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. BIOPSY GUIDANCE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOPSY GUIDANCE SYSTEM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BRAIN BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BRAIN BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LUNGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LUNGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PROSTATE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PROSTATE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 39. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 40. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 41. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 42. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 43. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 44. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 45. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 46. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 47. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 48. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 49. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 50. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 51. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 52. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 53. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 54. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 55. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 56. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 57. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 58. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 59. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 60. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 61. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 62. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 63. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 64. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 65. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 66. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 69. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 70. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 71. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 72. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 73. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 74. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 78. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 80. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 82. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 83. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 84. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 85. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 86. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 87. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 88. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 89. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 90. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 91. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 92. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 93. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 94. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 95. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 96. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 97. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 98. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 99. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 100. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 101. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 102. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 103. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 104. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 105. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 106. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 107. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 108. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 109. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 110. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 111. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 112. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 113. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 114. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 115. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 116. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 117. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 118. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 119. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 120. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 121. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 122. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 123. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 124. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 125. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 126. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 127. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 128. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 129. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 130. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 132. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 134. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 135. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 136. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 137. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 138. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 139. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 140. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 141. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 142. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 143. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 144. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 145. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 146. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 147. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 148. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 149. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 150. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 151. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 152. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 153. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 154. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 162. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 163. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 164. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 165. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 166. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 167. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 168. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 169. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 170. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 171. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 172. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 173. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 174. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 175. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 176. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 177. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 178. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 179. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 180. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 181. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 182. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 183. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 184. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 185. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 186. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 187. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 188. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 189. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 190. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 191. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 192. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 193. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 194. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 195. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 196. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 197. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 198. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 199. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 200. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 201. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 202. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 203. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 204. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 205. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 206. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 207. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 208. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 209. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 210. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 211. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 212. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 213. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 214. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 215. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 216. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 217. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 218. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 219. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 220. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 221. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 222. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 223. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 224. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 225. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 226. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 227. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 228. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 229. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 230. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 231. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 232. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 233. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 234. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 235. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 236. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 237. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 238. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 239. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 240. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 242. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 244. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 245. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 246. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 248. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 250. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 251. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 252. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 253. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 254. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 255. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 256. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 257. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 258. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 259. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 260. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 261. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 262. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 263. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 264. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 265. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 266. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 267. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 268. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 269. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 270. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 271. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 272. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 273. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 274. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 275. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 276. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 281. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 282. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 284. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 286. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 287. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 288. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 289. BIOPSY GUIDANCE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 290. BIOPSY GUIDANCE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

[191 Pages Report] The Biopsy Guidance System Market size was estimated at USD 1.44 billion in 2023 and expected to reach USD 1.54 billion in 2024, at a CAGR 7.34% to reach USD 2.38 billion by 2030.

The biopsy guidance system market encompasses the sales and development of medical devices and software that assist physicians in accurately locating the site for biopsy procedures. These biopsy guidance systems utilize a variety of modalities such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and other image-guided technologies to provide real-time assistance in accurately locating and targeting abnormal tissue for a biopsy. The growing incidences of cancer and gastrointestinal diseases is increasing the need for biopsy guidance systems. The rising awareness of breast cancer treatment & diagnosis and increasing preference for minimally invasive biopsy treatments has significantly contributing to the market growth. However, high cost associated with the production of biopsy guidance systems may limit the adoption of biopsy guidance systems. Technical complexities associated with biopsy guidance systems are also a concerning factor for the market growth. Moreover, the technological advancements in biopsy guidance systems is expected to create significant growth potential in the market. Improved healthcare infrastructure and healthcare spending are also anticipated to generate attractive opportunities for the market growth.

Product: Increasing inclination towards ultrasound guided biopsy for improved imaging capabilities

The MRI-guided biopsy is a minimally invasive procedure that utilizes magnetic resonance imaging (MRI) to aid in the precise location of a lesion within the body for tissue sampling. The MRI-guided biopsy is preferred in accessing abnormalities in case lesions are not visible using ultrasound or X-ray imaging. A stereotactic-guided biopsy employs mammographic imaging to locate and sample suspicious areas, particularly within the breast tissue. Stereotactic-guided biopsies provide high accuracy and cost-effectiveness, making them a preferred choice for outpatient settings. An ultrasound-guided biopsy is a widely employed technique that uses ultrasonography to assist in needle placement for tissue sampling. The ultrasound-guided biopsy is particularly suitable for palpable masses and commonly used for biopsies of the breast, thyroid, liver, kidneys, and other soft tissues, offering real-time imaging capabilities.

Application: Improved applications for breast biopsies for enhanced accuracy

Biopsy guidance systems are vital in brain biopsies to minimize damage to surrounding healthy tissue and improve precision. Advanced biopsy guidance systems, such as stereotactic biopsy frames or neuronavigation systems, enable surgeons to pinpoint the lesion's exact location within the brain, reducing the procedure's invasiveness and improving overall outcomes. Biopsy guidance systems are important in breast biopsies due to accuracy in tissue sampling procedures. Innovations in biopsy guidance technology, such as 3D imaging and computer-aided detection, are enhancing the precision of breast biopsies and helping to identify lesions that are difficult to track with conventional methods.

End-Use: Adoption of biopsy guidance systems in hospitals to enable high-quality imaging for diagnostic applications

Diagnostic centers are facilities that perform medical testing and imaging to diagnose patient conditions. These centers tend to favor cost-effective biopsy guidance systems with a smaller footprint to accommodate space constraints. Hospitals are primary healthcare facilities that require comprehensive biopsy guidance systems that can cater to high patient volumes and broad procedural needs. These systems must provide higher imaging quality and interoperability to align with multiple hospital departments. Research and academic institutes often utilize biopsy guidance systems for experimental and educational procedures. Specialty clinics, such as oncology or gastroenterology practices, require specialized biopsy guidance systems for particular types of biopsies. These clinics have a need for biopsy systems that provide precision and are tailored to the specific anatomy and conditions they frequently encounter.

Regional Insights

The Americas region is characterized by the presence of advanced healthcare infrastructure, higher healthcare spending, and a greater emphasis on early diagnosis and personalized medicine, which fuels the need for sophisticated biopsy guidance systems. Additionally, this region remains a hub for innovative startups and established companies seeking to improve the performance of cancer diagnostics. The European Union is associated with the widespread adoption of biopsy guidance systems due to the region's strong healthcare policies and well-established reimbursement frameworks. There is an emphasis on quality healthcare with a focus on advanced medical devices. The EU's regulatory environment also supports innovation through funding initiatives and facilitates research collaborations between private and public players. Asia Pacific is a rapidly growing region in the biopsy guidance system market. In China, large-scale investments in healthcare and growing public awareness about cancer are key factors propelling the need for biopsy guidance systems. The Chinese government's initiatives to reform healthcare and emphasis on emerging medical technologies have driven the adoption of advanced biopsy systems. Technological innovation, high healthcare standards, and a rapidly aging population drive Japan's need for biopsy guidance systems.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopsy Guidance System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopsy Guidance System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopsy Guidance System Market, highlighting leading vendors and their innovative profiles. These include Argon Medical Devices, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biobot Surgical Pte Ltd., Body Vision Medical Ltd., Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Danaher Corporation, Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., IMS Giotto S.p.A, Inomed Health Limited, INRAD Inc., IZI Medical Products, KOELIS, Koninklijke Philips N.V., KPI Healthcare India pvt Ltd, Mauna Kea Technologies, Medtronic PLC, Merit Medical Systems, NeoDynamics AB, Olympus Corporation, Planmed Oy, Siemens Healthineers AG, STERYLAB S.r.l., Stryker Corporation, and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Biopsy Guidance System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • MRI Guided Biopsy
  • Stereotactic Guided Biopsy
  • Ultrasound Guided Biopsy

• Application
  • Brain Biopsy
  • Breast Biopsy
  • Lungs
  • Prostate

• End-Use
  • Diagnostic Centers
  • Hospitals
  • Research & Academic Institutes
  • Specialty Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biopsy Guidance System Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopsy Guidance System Market?

3. What are the technology trends and regulatory frameworks in the Biopsy Guidance System Market?

4. What is the market share of the leading vendors in the Biopsy Guidance System Market?

5. Which modes and strategic moves are suitable for entering the Biopsy Guidance System Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of cancer and chronic diseases requiring diagnostic procedures
    • 5.1.1.2. Increasing preference for minimally invasive biopsy treatments
    • 5.1.1.3. Government campaigns and initiatives for early disease diagnosis
  • 5.1.2. Restraints
    • 5.1.2.1. Need for specialized training and inaccuracy of biopsy systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in biopsy guidance systems
    • 5.1.3.2. Favorable reimbursement policies for biopsy procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Technical complexities associated with biopsy guidance system
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing inclination towards ultrasound guided biopsy for improved imaging capabilities
  • 5.2.2. Application: Improved applications for breast biopsies for enhanced accuracy
  • 5.2.3. End-Use: Adoption of biopsy guidance systems in hospitals to enable high-quality imaging for diagnostic applications
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Biopsy Guidance System Market, by Product

• 6.1. Introduction
• 6.2. MRI Guided Biopsy
• 6.3. Stereotactic Guided Biopsy
• 6.4. Ultrasound Guided Biopsy

7. Biopsy Guidance System Market, by Application

• 7.1. Introduction
• 7.2. Brain Biopsy
• 7.3. Breast Biopsy
• 7.4. Lungs
• 7.5. Prostate

8. Biopsy Guidance System Market, by End-Use

• 8.1. Introduction
• 8.2. Diagnostic Centers
• 8.3. Hospitals
• 8.4. Research & Academic Institutes
• 8.5. Specialty Clinics

9. Americas Biopsy Guidance System Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Biopsy Guidance System Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Biopsy Guidance System Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. FDA Clears MRI-Compatible Robotics System for Breast Biopsy
  • 12.3.2. Stryker Launches Q Guidance with Cranial Guidance Software
  • 12.3.3. GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio